THE UPREGULATION OF NICOTINIC RECEPTORS
烟碱受体的上调
基本信息
- 批准号:7287655
- 负责人:
- 金额:$ 27.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAntibodiesBehavioralBindingBinding SitesBiochemistry and Pharmacology Cancer ActivityBiological AssayBrainBrain regionCell LineCell surfaceCessation of lifeChemicalsChimera organismChronicCollaborationsConsensusDataDependenceExposure toGoalsHealthHealth Care CostsLaboratoriesLinkLong-Term PotentiationMeasuresMethodsMolecular BiologyMolecular ConformationNeuronsNicotineNicotine DependenceNicotinic ReceptorsNumbersPharmacologyPost-Translational Protein ProcessingRadioRattusResearchResearch PersonnelRoleShapesSignal PathwaySpecificitySurfaceSystemTestingTimeTobaccoTobacco smokingUnited StatesUp-RegulationVentral Tegmental Areaaddictiondopaminergic neurondrug of abusein vivoprogramsreceptorreceptor functionreceptor upregulationresearch studyresponsetrafficking
项目摘要
Tobacco smoking is a major health problem leading each year to $50 billion dollars in health costs and
400,000 deaths in the United States. Significant evidence indicates that nicotine is the component in tobacco
leading to abuse and addiction. Nicotine binds to nicotinic receptors found in the brain. To characterize the
molecular biology of nicotine addiction, our research will focus on nicotinic receptors in the brain and how
nicotine-induced changes in nicotinic receptors correlates with aspects of addiction.
Like other drugs of abuse, many of the addictive effects of nicotine appear to result from the stimulation of
dopaminergic, mesolimbic neurons, in particular dopaminergic neurons from the ventral tegmental area
(VTA). The short-term effects of nicotine are caused by the activation of nicotinic receptors on these
neurons. Long-term exposure to nicotine enhances or "sensitizes" the response of these neurons to
nicotine, which correlates with the enhancement or "upregulation" of high-affinity binding to nicotinic
receptors. The goals of this proposal are: 1) to identify nicotinic receptor subtypes involved in nicotine
upregulation, 2) to identify mechanisms involved in nicotine upregulation of different nicotinic receptor
subtypes and 3) to test whether nicotinic receptor upregulation by nicotine is involved in nicotine-induced
long-term potentiation and behavorial/chemical sensitization as a collaboration with Projects 2 and 3. The
hypotheses to be tested are that: 1) nicotinic receptor upregulation in heterologous expression systems and
in vivo is caused by a receptor state change that causes the receptors to enter a hypersensitive or
functionally upregulated state; 2) nicotine-induced long-term potentiation and sensitization of the nicotine
response are initiated, at least in part, by receptor upregulation. Several possible nicotinic subunit
combinations will be expressed to test whether upregulation occurs for each combination and the extent to
which upregulation is a change in receptor number or entry into a hypersensitive state. Additional
experiments will assay for nicotinic receptor upregulation in brain after nicotine exposure in rats. These
experiments will test whether nicotine exposure, which induces locomotor sensitization, causes nicotinic
receptor upregulation in the brain regions identified with locomotor sensitization and examine which nicotinic
receptor subtypes are upregulated in these brain regions.
吸烟是一个主要的健康问题,每年导致500亿美元的健康成本,
美国有40万人死亡。大量证据表明,尼古丁是烟草中的一种成分,
导致滥用和成瘾。尼古丁与大脑中的烟碱受体结合。表征
尼古丁成瘾的分子生物学,我们的研究将集中在大脑中的尼古丁受体,以及如何
烟碱诱导的烟碱受体的变化与成瘾的各个方面相关。
像其他滥用药物一样,尼古丁的许多成瘾作用似乎是由刺激
多巴胺能中脑边缘神经元,特别是来自腹侧被盖区的多巴胺能神经元
(VTA)。尼古丁的短期效应是由这些细胞上的烟碱受体激活引起的。
神经元长期暴露于尼古丁增强或“敏感”这些神经元的反应,
尼古丁,其与尼古丁的高亲和力结合的增强或“上调”相关。
受体。本研究的目标是:1)鉴定尼古丁受体亚型,
上调,2)鉴定参与不同烟碱受体的烟碱上调的机制
亚型和3)测试尼古丁引起的烟碱受体上调是否涉及尼古丁诱导的细胞凋亡。
与项目2和项目3合作开展长期增效和杀虫剂/化学增敏。的
待检验的假设是:1)异源表达系统中烟碱受体上调,
在体内是由受体状态变化引起的,该变化导致受体进入超敏或
功能上调状态; 2)尼古丁诱导的尼古丁长时程增强和敏化
应答至少部分是通过受体上调而启动的。几种可能的烟碱亚基
将表达组合以测试每种组合是否发生上调以及上调的程度。
所述上调是受体数量的变化或进入过敏状态。额外
实验将测定大鼠暴露于尼古丁后大脑中尼古丁受体的上调。这些
实验将测试尼古丁暴露是否会引起运动敏化,
受体上调的大脑区域确定与运动敏化,并检查哪些尼古丁
受体亚型在这些脑区域中上调。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM GREEN其他文献
WILLIAM GREEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM GREEN', 18)}}的其他基金
Different components of nicotine-induced upregulation of nicotinic receptors - E. Hunpatin Supplement
尼古丁诱导的烟碱受体上调的不同成分 - E. Hunpatin 补充剂
- 批准号:
9271673 - 财政年份:2016
- 资助金额:
$ 27.9万 - 项目类别:
Organization and Dynamics of PSD-bound Glutamate Receptors at Super-resolution
超分辨率下 PSD 结合谷氨酸受体的组织和动态
- 批准号:
8929506 - 财政年份:2014
- 资助金额:
$ 27.9万 - 项目类别:
Different components of nicotine-induced upregulation of nicotinic receptors
尼古丁诱导烟碱受体上调的不同成分
- 批准号:
8584938 - 财政年份:2013
- 资助金额:
$ 27.9万 - 项目类别:
Different components of nicotine-induced upregulation of nicotinic receptors
尼古丁诱导烟碱受体上调的不同成分
- 批准号:
8710143 - 财政年份:2013
- 资助金额:
$ 27.9万 - 项目类别:
Different components of nicotine-induced upregulation of nicotinic receptors
尼古丁诱导烟碱受体上调的不同成分
- 批准号:
9267467 - 财政年份:2013
- 资助金额:
$ 27.9万 - 项目类别:
Different components of nicotine-induced upregulation of nicotinic receptors
尼古丁诱导烟碱受体上调的不同成分
- 批准号:
8840209 - 财政年份:2013
- 资助金额:
$ 27.9万 - 项目类别:
Different components of nicotine-induced upregulation of nicotinic receptors
尼古丁诱导烟碱受体上调的不同成分
- 批准号:
9271674 - 财政年份:2013
- 资助金额:
$ 27.9万 - 项目类别:
Proteomic Assays of Neuronal Protein Palmitoylation
神经元蛋白棕榈酰化的蛋白质组学测定
- 批准号:
7996534 - 财政年份:2009
- 资助金额:
$ 27.9万 - 项目类别:
Proteomic Assays of Neuronal Protein Palmitoylation
神经元蛋白棕榈酰化的蛋白质组学测定
- 批准号:
7839651 - 财政年份:2009
- 资助金额:
$ 27.9万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 27.9万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 27.9万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 27.9万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 27.9万 - 项目类别: